Research CompoundsFeatured

Retatrutide 20mg

CAS: 2381272-89-3

Retatrutide is a synthetic peptide triple agonist targeting the glucose-dependent insulinotropic polypeptide (GIP) receptor, glucagon-like peptide-1 (GLP-1) receptor, and glucagon receptor simultaneously. This tri-agonist mechanism distinguishes it from dual agonists and is the subject of active preclinical and clinical metabolic research. Supplied as 20 mg lyophilized powder.

GIP AgonistGLP-1 AgonistGlucagon AgonistTriple AgonistMetabolic
Verified Purity
99.2%

Determined by HPLC analysis. Certificate of Analysis available upon request.

Amino Acid Sequence

Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Gly-Leu-Leu-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Lys-Lys-Lys-Gly-Gly-Ser-NH2

price

$130.00

Storage

Store at -20°C. Protect from light and moisture. Stable for 24 months when stored properly.

Solubility

Soluble in water (1 mg/mL) or PBS pH 7.4

For research use only. Not for human or veterinary use.